PURE BiosciencePURE 
$0.06-14.29%24h
-14.29%24h
Global rank33855
Market cap$6.68M
Change 7d-14.29%
YTD Performance-57.14%
SP500 benchmarkUnderperform
P/E-1.50
P/S3.56
Revenue$1.88M
Earnings-$3.96M
Dividend yield-
Main Sector
Consumer Defensive
PURE Bioscience PURE Operating Margins
Operating Margin in 2022: -1.93%
According to PURE Bioscience latest financial reports the company has an operating margin of -1.93%, an increase of 6.28% to 2022. At the end of 2022 company had an operating margin of -1.82%.
PURE Bioscience Operating Margin from 2020 to 2024
-
Value:-
PURE Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -1.93% | 6.28% |
| 2022 | -1.82% | 209.04% |
| 2021 | -0.59% | -101864.62% |
| 2020 | 0.00% | - |
View the highest operating margin companies 
